person · Reporting owner

TERRELL JASON BRADLEY MD

Disclosed activity across 1 company

Tapewire entity: 124881
SEC CIK: 0001567531

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
VOLITIONRX LTDVNRX · Entity 8241	Chief Medical Officer	August 03, 2022	August 05, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

VOLITIONRX LTD

Report date August 03, 2022 · Filed August 05, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	30,866	Reported balance After 2022-08-03 transaction · row 1 1 source row Row 1 · 2022-08-03 · Tax withholding · Disposed 4,279 · Balance 30,866 F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 17,573 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
Common StockSEC Table I · non-derivative	IndirectBy Spouse	2,326	Reported balance After 2022-08-03 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2022-08-03 · Tax withholding · Disposed 404 · Balance 2,326 F2: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the spouse of the reporting person upon settlement of 1,365 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 17,573 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

F2: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the spouse of the reporting person upon settlement of 1,365 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 30, 2017 Filed Apr 3, 2017 20:41 UTC	VOLITIONRX LTD VNRX · Entity 8241	GrantStock Option (Right to Buy) · Derivative	50,000	$0.00 Strike: $5.00	$0.00	Disclosure SEC source: 0001078782-17-000415 · primary_doc.xml · derivative · entry 1 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 50,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document
February 14, 2017 Filed Feb 15, 2017 18:11 UTC	VOLITIONRX LTD VNRX · Entity 8241	GrantWarrant (Right to Buy) · Derivative	25,000	$0.00 Strike: $2.47	$0.00	Disclosure SEC source: 0001078782-17-000206 · primary_doc.xml · derivative · entry 2 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · kind: The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The replacement warrant amends the performance criteria for a vesting milestone. F2 · derivative.exercise_date: The date exercisable is variable and depends on the achievement of the performance criteria outlined in the warrant agreement, as amended. F3 · derivative.expiration_date: The subject warrant shall expire three years after the vesting date. Read SEC document
February 14, 2017 Filed Feb 15, 2017 18:11 UTC	VOLITIONRX LTD VNRX · Entity 8241	Disposition to issuerWarrant (Right to Buy) · Derivative	25,000	$0.00 Strike: $2.47	$0.00	Disclosure SEC source: 0001078782-17-000206 · primary_doc.xml · derivative · entry 1 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · kind: The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The replacement warrant amends the performance criteria for a vesting milestone. F2 · derivative.exercise_date: The date exercisable is variable and depends on the achievement of the performance criteria outlined in the warrant agreement, as amended. F3 · derivative.expiration_date: The subject warrant shall expire three years after the vesting date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.